Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial

de Gregorio, Amelie; Haberle, Lothar; Fasching, Peter A.; Mueller, Volkmar; Schrader, Iris; Lorenz, Ralf; Forstbauer, Helmut; Friedl, Thomas W. P.; Bauer, Emanuel; de Gregorio, Nikolaus; Deniz, Miriam; Fink, Visnja; Bekes, Inga; Andergassen, Ulrich; Schneeweiss, Andreas; Tesch, Hans; Mahner, Sven; Brucker, Sara Y.; Blohmer, Jens-Uwe; Fehm, Tanja N.; Heinrich, Georg; Lato, Krisztian; Beckmann, Matthias W.; Rack, Brigitte; Janni, Wolfgang

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial

Autor(en):

de Gregorio, Amelie; Haberle, Lothar; Fasching, Peter A.; Mueller, Volkmar; Schrader, Iris; Lorenz, Ralf; Forstbauer, Helmut; Friedl, Thomas W. P.; Bauer, Emanuel; de Gregorio, Nikolaus; Deniz, Miriam; Fink, Visnja; Bekes, Inga; Andergassen, Ulrich; Schneeweiss, Andreas; Tesch, Hans; Mahner, Sven; Brucker, Sara Y.; Blohmer, Jens-Uwe; Fehm, Tanja N.; Heinrich, Georg; Lato, Krisztian; Beckmann, Matthias W.; Rack, Brigitte; Janni, Wolfgang

Tübinger Autor(en):

Brucker, Sara

Erschienen in:

Breast Cancer Research (2020), Bd. 22, Article 111

Verlagsangabe:

Bmc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1186/s13058-020-01348-w

ISSN:

1465-542X